We are live on ! Find out more
AP

Advisor Partners Portfolio holdings

AUM $1.42B
1-Year Est. Return 3.97%
This Fund
S&P 500
This Quarter Est. Return
+10.34%
1 Year Est. Return
-3.97%
3 Year Est. Return
+63.81%
5 Year Est. Return
+114.27%
10 Year Est. Return
AUM
$1.17B
AUM Growth
+$92.6M
Cap. Flow
+$1.66M
Cap. Flow %
0.14%
Top 10 Hldgs %
26.4%
Holding
723
New
39
Increased
345
Reduced
308
Closed
24

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.44M
2
GILD icon
Gilead Sciences
GILD
+$1.42M
3
C icon
Citigroup
C
+$1.29M
4
INTC icon
Intel
INTC
+$1.27M
5
CSCO icon
Cisco
CSCO
+$1.27M

Sector Composition

Rank Sector Weight
1 Technology 24.51%
2 Healthcare 14.63%
3 Financials 13.76%
4 Consumer Discretionary 10.63%
5 Communication Services 9.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRU icon
101
Prudential Financial
PRU
$41.5B
$2.24M 0.19%
35,276
-73
-0.2% -$4.8K
MS icon
102
Morgan Stanley
MS
$337B
$2.23M 0.19%
46,046
+381
+0.8% +$19.2K
AZN icon
103
AstraZeneca
AZN
$255B
$2.16M 0.19%
19,724
+1,065
+6% +$118K
NOC icon
104
Northrop Grumman
NOC
$77.4B
$2.15M 0.18%
6,801
-148
-2% -$48.3K
EQIX icon
105
Equinix
EQIX
$106B
$2.14M 0.18%
2,820
+36
+1% +$27.2K
CME icon
106
CME Group
CME
$101B
$2.09M 0.18%
12,508
+928
+8% +$156K
LHX icon
107
L3Harris
LHX
$48.8B
$2.09M 0.18%
12,306
-159
-1% -$27.9K
BIIB icon
108
Biogen
BIIB
$32.7B
$2.08M 0.18%
7,349
-30
-0.4% -$8.37K
VRTX icon
109
Vertex Pharmaceuticals
VRTX
$139B
$2.07M 0.18%
7,609
-201
-3% -$55.5K
TJX icon
110
TJX Companies
TJX
$148B
$2.06M 0.18%
37,069
+1,094
+3% +$59K
BDX icon
111
Becton Dickinson
BDX
$51.2B
$2.04M 0.17%
8,963
-631
-7% -$155K
GILD icon
112
Gilead Sciences
GILD
$185B
$2.03M 0.17%
32,080
-20,545
-39% -$1.42M
ASML icon
113
ASML
ASML
$666B
$2.02M 0.17%
5,481
+143
+3% +$53.5K
PGR icon
114
Progressive
PGR
$126B
$2M 0.17%
21,080
+129
+0.6% +$11.6K
PNC icon
115
PNC Financial Services
PNC
$97.1B
$1.98M 0.17%
18,005
+347
+2% +$37.3K
SO icon
116
Southern Company
SO
$102B
$1.97M 0.17%
36,346
-2,646
-7% -$141K
EW icon
117
Edwards Lifesciences
EW
$51.8B
$1.97M 0.17%
24,667
+3,038
+14% +$237K
WY icon
118
Weyerhaeuser
WY
$17.1B
$1.96M 0.17%
68,616
-892
-1% -$24.5K
CI icon
119
Cigna
CI
$73.4B
$1.95M 0.17%
11,517
-2,656
-19% -$467K
SYK icon
120
Stryker
SYK
$124B
$1.95M 0.17%
9,334
+273
+3% +$53.1K
ADP icon
121
Automatic Data Processing
ADP
$113B
$1.94M 0.17%
13,885
+74
+0.5% +$10.4K
ISRG icon
122
Intuitive Surgical
ISRG
$130B
$1.93M 0.17%
8,166
-66
-0.8% -$14.8K
NVO
123
Novo Nordisk
NVO
$205B
$1.93M 0.17%
55,636
+1,858
+3% +$61.9K
AON icon
124
Aon
AON
$74.2B
$1.92M 0.16%
9,316
-291
-3% -$58.1K
BKNG icon
125
Booking.com
BKNG
$152B
$1.92M 0.16%
28,025
-475
-2% -$33.4K

Similar funds

Advisor Partners's Q3 2020 Portfolio in Review

As of Q3 2020, Advisor Partners held 723 positions worth $1.17B, up 8.6% from $1.07B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Advisor Partners's Q3 2020 filing shows 39 new, 345 increased, 308 reduced and 24 closed positions. Its largest new stake was ORIX: 59,180 shares worth $741K. The largest sale was Apple, an estimated $1.44M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

  • Advisor Partners's largest Q3 2020 buy was ORIX: 59,180 shares worth $741K.
  • Advisor Partners added most to Berkshire Hathaway Class B in Q3 2020, an estimated $1.3M increase.
  • Advisor Partners's biggest Q3 2020 reduction was Apple, cutting an estimated $1.44M.
  • Advisor Partners fully exited Barnes Group Inc. in Q3 2020, selling an estimated $345K.
  • Advisor Partners's ten largest holdings make up 26% of its $1.17B portfolio in Q3 2020.
  • Advisor Partners opened 39 new positions and closed 24 in Q3 2020.
  • Advisor Partners's portfolio value rose 8.6% quarter-over-quarter to $1.17B.

Based on Advisor Partners's 13F filing for Q3 2020, filed 5 Nov 2020.